Suggestions
Kunhua Chen
exonbio
Kunhua Chen is the Chief Executive Officer (CEO) of Exonbio, a company specializing in recombinant protein and antibody development. He has been instrumental in leading the company's efforts, particularly in the development of monoclonal antibodies using their proprietary Single Plasma cell INterrogation (SPIN®) technology. This technology allows for the creation of high-affinity antibodies, which are crucial for therapeutic and diagnostic applications, including those related to COVID-19.13
Background and Experience::
- Education: Kunhua Chen is an alumnus of Rutgers University.
- Previous Roles: Before joining Exonbio, he held positions at Exon Biosystems and the Salk Institute, contributing to his extensive experience in the biotechnology field.23
Current Role:: As CEO, Chen oversees the strategic direction of Exonbio and its research initiatives. Under his leadership, the company has launched various products aimed at enhancing research capabilities in understanding and combating diseases like COVID-19.14
For more details about his professional background, you can view his LinkedIn profile here .2
